True Bearing Asset Management’s Lifecore Biomedical LFCR Stock Holding History

True Bearing Asset Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-35,579	Closed	-$421K	–	58
2015 Q4	$421K	Sell	35,579 -68,500	-66%	-$841K	0.84%	45
2015 Q3	$1.22M	Buy	104,079 +10,919	+12%	+$145K	2.06%	17
2015 Q2	$1.34M	Sell	93,160 -59,073	-39%	-$853K	1.67%	29
2015 Q1	$2.12M	Sell	152,233 -48,163	-24%	-$665K	1.31%	34
2014 Q4	$2.77M	Sell	200,396 -40,000	-17%	-$517K	1.37%	26
2014 Q3	$2.94M	Hold	240,396	–	–	1.51%	20
2014 Q2	$3M	Hold	240,396	–	–	1.56%	17
2014 Q1	$2.68M	Sell	240,396 -19,620	-8%	-$215K	1.51%	22
2013 Q4	$3.15M	Hold	260,016	–	–	1.5%	18
2013 Q3	$3.17M	Sell	260,016 -21,793	-8%	-$304K	1.59%	15
2013 Q2	$3.72M	Buy	+281,809	New	+$3.9M	1.89%	6

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

True Bearing Asset Management's LFCR Position: Q1 2016 in Review

True Bearing Asset Management sold out of Lifecore Biomedical (LFCR) in Q1 2016, closing a stake of 35,579 shares — an estimated $421K sold.

True Bearing Asset Management first reported a position in LFCR in Q2 2013 and held it in 11 quarters. The position peaked at $3.72M in Q2 2013. 96 funds tracked by Wall St. Rank hold LFCR as of Q1 2016.

True Bearing Asset Management reported no remaining Lifecore Biomedical position as of Q1 2016 after selling out during the quarter.
True Bearing Asset Management sold 35,579 Lifecore Biomedical shares in Q1 2016, an estimated $421K.
True Bearing Asset Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 11 quarters.
True Bearing Asset Management's Lifecore Biomedical position peaked at $3.72M in Q2 2013.
96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2016.

Based on True Bearing Asset Management's 13F filing for Q1 2016, filed 16 May 2016.